129 related articles for article (PubMed ID: 29113851)
1. Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma.
Hauser A; Dutta SW; Showalter TN; Sheehan JP; Grover S; Trifiletti DM
J Clin Neurosci; 2018 Jan; 47():103-110. PubMed ID: 29113851
[TBL] [Abstract][Full Text] [Related]
2. Impact of facility type and volume on post-surgical outcomes following diagnosis of WHO grade II glioma.
Mahato D; De Biase G; Ruiz-Garcia HJ; Grover S; Rosenfeld S; Quiñones-Hinojosa A; Trifiletti DM
J Clin Neurosci; 2018 Dec; 58():34-41. PubMed ID: 30366782
[TBL] [Abstract][Full Text] [Related]
3. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
[TBL] [Abstract][Full Text] [Related]
5. Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis.
Cannon RB; Carpenter PS; Boothe D; Buchmann LO; Hunt JP; Lloyd S; Hitchcock YJ; Houlton JJ; Weis JR; Shepherd HM; Monroe MM
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):473-483. PubMed ID: 29661049
[TBL] [Abstract][Full Text] [Related]
6. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Lopez Ramos C; Brandel MG; Steinberg JA; Wali AR; Rennert RC; Santiago-Dieppa DR; Sarkar RR; Pannell JS; Murphy JD; Khalessi AA
J Neurooncol; 2019 Jan; 141(1):159-166. PubMed ID: 30460629
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
8. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
9. The utilization of MGMT promoter methylation testing in United States hospitals for glioblastoma and its impact on prognosis.
Lee A; Youssef I; Osborn VW; Safdieh J; Becker DJ; Schreiber D
J Clin Neurosci; 2018 May; 51():85-90. PubMed ID: 29483008
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
11. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
Rhome R; Fisher R; Hormigo A; Parikh RR
J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
[TBL] [Abstract][Full Text] [Related]
12. The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2021 Apr; 21(1):387. PubMed ID: 33836694
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in head and neck oncologic surgery at academic medical centers in the United States.
Jalisi S; Bearelly S; Abdillahi A; Truong MT
Laryngoscope; 2013 Mar; 123(3):689-98. PubMed ID: 23444189
[TBL] [Abstract][Full Text] [Related]
14. Patterns of management and outcomes of unifocal versus multifocal glioblastoma.
Haque W; Thong Y; Verma V; Rostomily R; Brian Butler E; Teh BS
J Clin Neurosci; 2020 Apr; 74():155-159. PubMed ID: 32089384
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset.
Field KM; Drummond KJ; Yilmaz M; Tacey M; Compston D; Gibbs P; Rosenthal MA
J Clin Neurosci; 2013 Jun; 20(6):783-9. PubMed ID: 23639619
[TBL] [Abstract][Full Text] [Related]
16. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
[TBL] [Abstract][Full Text] [Related]
17. Regionalization of head and neck cancer surgery may fragment care and impact overall survival.
Chen MM; Megwalu UC; Liew J; Sirjani D; Rosenthal EL; Divi V
Laryngoscope; 2019 Jun; 129(6):1413-1419. PubMed ID: 30152007
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between the Residual Tumor Volume, Extent of Tumor Resection, and O
Sharma M; Bellamkonda S; Mohapatra S; Meola A; Jia X; Mohammadi A; Angelov L; Barnett GH; Vogelbaum M; Ahluwalia MS
World Neurosurg; 2018 Aug; 116():e147-e161. PubMed ID: 29709748
[TBL] [Abstract][Full Text] [Related]
19. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
20. Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson's disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010.
Sharma M; Ambekar S; Guthikonda B; Wilden J; Nanda A
Neurosurg Focus; 2013 Nov; 35(5):E2. PubMed ID: 24175862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
